The Effects of Medications and the Roles of Pharmacists on the Recovery of Patients with COVID-19 Infection : An Epidemiological Study from the United Arab Emirates

Patients infected with coronavirus have new experiences and hence new needs from the healthcare sector. Acknowledging patients' experiences can exhibit promising outcomes in coronavirus management. Pharmacists are considered a vital pillar in managing patients' experiences during their infection. A cross-sectional study was conducted to assess the experiences of COVID-19-infected individuals and the roles of pharmacists in the United Arab Emirates. The survey was face- and content-validated after being developed. Three sections were included in the survey (demographics, experiences of infected individuals, and the roles of pharmacists). Data were analyzed using the Statistical Package for the Social Sciences. The study participants (n = 509) had a mean age of 34.50 (SD = 11.93). The most reported symptoms among participants were fatigue (81.5%), fever (76.8%), headache (76.6%), dry cough (74.1%), muscle or joint pain (70.7%), and sore throat (68.6%). Vitamin C was the most used supplement (88.6%), followed by pain relievers (78.2%). Female gender was the only factor associated with symptom severity. About 79.0% agreed that the pharmacist played an important and effective role during their infection. The most reported symptom was fatigue, with females reporting more severe symptoms. The role of the pharmacist proved to be vital during this pandemic.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Healthcare (Basel, Switzerland) - 11(2023), 4 vom: 06. Feb.

Sprache:

Englisch

Beteiligte Personen:

Basheti, Iman A [VerfasserIn]
Barqawi, Hiba [VerfasserIn]
Nassar, Razan I [VerfasserIn]
Thiab, Samar [VerfasserIn]
Atatreh, Noor [VerfasserIn]
Abu-Gharbieh, Eman [VerfasserIn]

Links:

Volltext

Themen:

COVID-19
Coronavirus
Journal Article
Pandemics
Pharmacists
United Arab Emirates

Anmerkungen:

Date Revised 28.02.2023

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/healthcare11040467

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM353391387